BNR
NASD Burning Rock Biotech Ltd. Sponsored ADR$15.00 ↑ +0.00 (+0.00%) Trading Up from the previous close of $15.00, $0.59 below the day’s high of $15.59
- YTD change
- -25.56%
- vs 20-day SMA
- -3.43%
- vs 200-day SMA
- -12.55%
Price ranges
Price & Performance
-2.93 (-16.34%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 95.4% away from all-time highs of $324.00
- BNR is down 26% since the beginning of the year
- BNR is up 79% over the past 12 months
- BNR is up 22% over the past 1 month
- 0% of all BNR investors are betting against BNR
BNR reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +74.6%.
- Previous minute
- +$0.00
- Last hour
- -$0.10
- Last 5 days
- -7.69%
- vs 8-day SMA
- -6.01%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Burning Rock Biotech Ltd. engages in the investment of medical fields. It specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology. The firm operates through the following segments: Central Laboratory Business, In-Hospital Business and Pharma Research and Development Services. Its products and clinical applications include companion diagnostics for targeted therapy and immunotherapy, benign, malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction and tumor susceptibility tests. The company was founded by Yu Sheng Han in January 2014 and is headquartered in Guangzhou, China.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
